Companies: 10,795·Total market cap: $144.5T
Goldenwell Biotech, Inc.

Goldenwell Biotech, Inc.

GWLLOTCConsumer Defensive● Active
$0.52
+$0.00(+0.00%)
Market Cap$51480000
P/E Ratio—
52W High$10
52W Low$0.2
Overview

Goldenwell Biotech, Inc. (GWLL) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

GWLL · earnings · updated Jun 9, 2026

No earnings history available.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.35
Rev. Est.$8.07B
No earnings history available.
No analyst estimates available for GWLL.

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: GWLL ends December

Goldenwell Biotech, Inc. (GWLL) reports earnings quarterly as a OTC-listed Packaged Foods company. The next GWLL earnings date is expected around September 1, 2026.

Each quarter, investors track GWLL earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GWLL revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GWLL's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

GWLL earnings · 3 questions

Goldenwell Biotech, Inc.'s next earnings report is expected around September 1, 2026. GWLL typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GWLL historically reports after market close (AMC).

GWLL earnings datewhen is GWLL earningsGWLL next earnings datewhen does GWLL report earningsGWLL earnings calendar

▸ Source: FMP · Goldenwell Biotech, Inc. SEC filings · US GAAP · Goldenwell Biotech, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026